期刊文献+

慢性乙型肝炎患者外周血Th17细胞和IL-17检测及其临床意义 被引量:12

原文传递
导出
摘要 目的观察慢性乙型肝炎(CHB)患者外周血Th17细胞表达频率和白细胞介素(IL)17浓度并探讨其临床意义。方法细胞内因子染色法结合流式细胞术检测20例CHB患者、6例慢加急性肝衰竭(ACLF)患者和19例健康对照(HC)组外周血Th17细胞表达频率,酶联免疫吸附法检测血浆IL-17浓度,分析Th17细胞表达频率和IL-17浓度与HBV DNA载量以及谷丙转氨酶(ALT)、凝血酶原活动度(PTA)、总胆红素(TB)水平之间的相关性。结果 CHB和ACLF患者Th17细胞表达频率为(3.34±1.79)%和(3.89±1.67)%,均高于健康对照组(2.01±0.78)%,CHB患者Th17细胞表达频率与ALT呈正相关(r=0.6188,P=0.0062)。CHB和ACLF患者血浆IL-17浓度[(168.8±53.86)pg/ml和(185.5±63.66)pg/ml]均低于健康对照[(260.8±100.30)pg/ml],CHB患者IL-17浓度与PTA负相关(r=-0.5803,P=0.0073),ACLF患者IL-17浓度与HBV DNA水平负相关(r=-0.8605,P=0.0278)。结论 CHB患者Th17细胞表达频率和IL-17浓度与肝脏损伤程度密切相关,可以作为判断CHB患者肝脏损伤程度的重要指标。
出处 《中华临床医师杂志(电子版)》 CAS 2011年第14期4264-4267,共4页 Chinese Journal of Clinicians(Electronic Edition)
基金 "十一五"江苏省高等学校重点学科建设专项资金(苏教研[2006]4号) 江苏省六大高峰人才基金(2011032)
  • 相关文献

参考文献15

  • 1张明海,赵建斌.Th17细胞在迟发性超敏反应相关性疾病中作用的研究进展[J].中华临床医师杂志(电子版),2010,4(12). 被引量:4
  • 2Liver Failure and Artificial Liver Group, Chinese Society of Infectious Diseases, Chinese Medical Association.肝衰竭诊疗指南[J].中华肝脏病杂志,2006,14(9):643-646. 被引量:832
  • 3病毒性肝炎防治方案[J].中华传染病杂志,2001,19(1):56-62. 被引量:1826
  • 4Rowan AG,Fletcher JM,Ryan EJ,et al.Hepatitis C virus-specific Th17 cells are suppressed by virus-induced TGF-beta. J Immunol . 2008
  • 5Zhang JY,Song CH,Shi F,et al.Decreased ratio of Treg cells to Th17 cells correlates with HBV DNA suppression in chronic hepatitis B patientsundergoing entecavir treatment. PLoS One . 2010
  • 6Zhang JY,Zhang Z,Lin F,et al.Interleukin-17-producing CD4(+)Tcells increase with severity of liver damage in patients with chronic hepatitisB. Hepatology . 2010
  • 7Wang YH,Voo KS,Liu B,et al.Anovel subset of CD4 (+)T (H)2 memory/effector cells that produce inflammatory IL-17 cytokine and promotethe exacerbation of chronic allergic asthma. The Journal of Experimental Medicine . 2010
  • 8Kebir H,Ifergan I,Alvarez JI,et al.Preferential recruitment of interferon-gamma-expressing TH17 cells in multiple sclerosis. Annals of Neurology . 2009
  • 9Hammerich L,Heymann F,Tacke F.Role of IL-17 and Th17 cellsin liver diseases. Clinical and Developmental Immunology . 2011
  • 10Sitia G,Iannacone M,Mller S,et al.Treatment with HMGB1inhibitors diminishes CTL-induced liver disease in HBVtransgenic mice. Journal of Leukocyte Biology . 2007

二级参考文献39

  • 1Lan-JuanLi QianYang Jian-RongHuang Xiao-WeiXu Yue-MeiChen Su-ZhenFu.Effect of artificial liver support system on patients with severe vira hepatitis:A study of four hundred cases[J].World Journal of Gastroenterology,2004,10(20):2984-2988. 被引量:80
  • 2拉米夫定临床应用专家组 ,万谟彬.2004年拉米夫定临床应用专家共识[J].中华肝脏病杂志,2004,12(7):425-428. 被引量:257
  • 3李梦东,聂青和.糖皮质激素治疗重型肝炎的临床及实验研究[J].实用肝脏病杂志,2005,8(1):1-6. 被引量:64
  • 4郑树森,徐骁.积极推进中国肝移植的发展[J].中华肝胆外科杂志,2005,11(7):437-439. 被引量:21
  • 5Chung Y,Chang SH,Martinez GJ,et al.Critical regulation of early Th17 cell differentiation by interleukin-1 signaling.Immunity,2009,30(4):576-587.
  • 6Mangan PR,Harrington LE,O′Quinn DB,et al.Transforming growth factor-beta induces development of the T(H)17 lineage.Nature,2006,441(7090):231-234.
  • 7Ichiyama K,Yoshida H,Wakabayashi Y,et al.Foxp3 inhibits RORgammat-mediated IL-17A mRNA transcription through direct interaction with RORgammat.J Biol Chem,2008,283(25):17003-17008.
  • 8Wright JF,Guo Y,Quazi A,et al,Identification of an interleukin 17F/17A heterodimer in activated human CD4 + T cells.J Biol Chem,2007,282(18):13447-13455.
  • 9Harrington LE,Mangan PR,Weaver CT.Expanding the effector CD4 T-cell repertoire:the Th17 lineage.Curr Opin Immunol,2006,18(3):349-356.
  • 10Cruz A,Khader SA,Torrado E,et al.Cutting edge:IFN-gamma regulates the induction and expansion of IL-17-producing CD4 T cells during mycobacterial infection.J Immunol,2006,177(3):1416-1420.

共引文献2682

同被引文献107

引证文献12

二级引证文献96

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部